Top 20 biopharma companies’ market caps rise 1.7% over 2024 amid policy
Eli Lilly achieved the largest market capitalisation growth of 32.4% to $733bn in 2024, driven by strong demand for Mounjaro ...
ALF Announces 2024 Recipients of Liver Scholar and Postdoctoral Research Fellowship Awards
American Liver Foundation (ALF) is thrilled to announce the recipients of its prestigious 2024 Liver Scholar and Postdoctoral Research Fellowship Awards. These awards are part of ALF's continued ...
Health on MSN9h
What To Know About Primary Sclerosing Cholangitis (PSC)
Medically reviewed by Jay N. Yepuri, MD Primary sclerosing cholangitis (PSC) is a progressive scarring of the liver's bile ...
GENFIT Announces 2025 Financial Calendar
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), January 29, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the ...
Money Talks News on MSN2d
Don't Ignore These Early Signs of a Progressive Liver Condition
A progressive liver condition affects thousands of Americans, but early symptoms are often dismissed as everyday ailments.
'My liver had turned into a tumour-making machine'
I wasn't ill apart from some tiredness.” After being on the organ donor waiting list for four months, Mandy was matched with ...
Tharimmune Inc.: Tharimmune to Present at the Microcap Conference 2025
BRIDGEWATER, NJ / ACCESS Newswire / January 27, 2025 / Tharimmune, Inc. (Nasdaq:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company committed to pioneering therapies in immun ...